Osaic Holdings
APVO icon

Osaic Holdings’s Aptevo Therapeutics APVO Stock Holding History

Osaic Holdings’s Portfolio APVO Stock Details APVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6K Hold
360
– – ﹤0.01% 7341
2026
Q1 		$1.54K Hold
360
– – ﹤0.01% 7133
2025
Q4 		$3.39K Sell
360
-1
-0.3% -$24 ﹤0.01% 6892
2025
Q3 		$9.8K Buy
361
+180
+99% +$7.23K ﹤0.01% 6373
2025
Q2 		$9.9K Buy
+181
New +$33K ﹤0.01% 6150
2025
Q1 		– Hold
0
– – – 7409
2024
Q4 		– Hold
0
– – – 7362
2024
Q3 		– Hold
0
– – – 7356
2024
Q2 		– Hold
0
– – – 7348
2024
Q1 		– Hold
0
– – – 6959
2023
Q4 		– Hold
0
– – – 7252
2023
Q3 		– Hold
0
– – – 7341
2023
Q2 		– Hold
0
– – – 7335
2023
Q1 		– Hold
0
– – – 7365
2022
Q4 		– Hold
0
– – – 7156
2022
Q3 		– Hold
0
– – – 7236
2022
Q2 		– Hold
0
– – – 7310
2022
Q1 		– Hold
0
– – – 7218
2021
Q4 		– Hold
0
– – – 7358
2021
Q3 		– Hold
0
– – – 7162

Other funds holding APVO

GSA Capital Partners
GSA Capital Partners London, United Kingdom $1.59B AUM 39.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Danske Bank
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Osaic Holdings's APVO Position: Q2 2026 in Review

Osaic Holdings held its Aptevo Therapeutics (APVO) position steady in Q2 2026 at 360 shares worth $1.6K. The position accounts for ﹤0.01% of the portfolio, ranked #7341.

Osaic Holdings first reported a position in APVO in Q2 2025 and has held it in 5 quarters since. The position peaked at $9.9K in Q2 2025. 9 funds tracked by Wall St. Rank hold APVO as of Q2 2026.

  • Osaic Holdings held 360 shares of Aptevo Therapeutics worth $1.6K as of Q2 2026.
  • Osaic Holdings left its Aptevo Therapeutics share count unchanged in Q2 2026.
  • Aptevo Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7341 holding.
  • Osaic Holdings first reported a position in Aptevo Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Osaic Holdings's Aptevo Therapeutics position peaked at $9.9K in Q2 2025.
  • 9 funds tracked by Wall St. Rank held Aptevo Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.